[Financing perspectives for multiparametric magnetic resonance prostatography]

Area of Science:

• Radiology
• Medical Diagnostics
• Health Economics

Background:

• Multiparametric magnetic resonance prostatography (mpmP) is evidence-based and recommended by the S3 guideline for prostate cancer prior to biopsy.
• Current reimbursement for mpmP is not available through statutory health insurance (GKV).

Purpose of the Study:

• To describe the complex registration procedure for including mpmP in the German Uniform Evaluation Standard (EBM) catalogue.
• To analyze the political and economic factors influencing EBM inclusion negotiations.

Main Methods:

• Radiology associations (BDR, DRG) provided evidence and quality assurance data.
• Special contracts with health insurance funds were coordinated at the federal state level to facilitate accreditation.

Main Results:

• The application for EBM approval included service definition, remuneration recommendations, supporting documents, and a quality assurance system.
• Submitted to the Joint Valuation Committee of physicians and health insurance funds.

Conclusions:

• The process highlights the role of radiology associations in advancing diagnostic methods.
• mpmP demonstrates the evolution of radiological techniques for specialized organ diagnostics.